Douglas I. Johnson
Professor
Department of Molecular Genetics and Miocrobiology
University of Vermont
United States of America
Biography
Dr. Johnson received his Ph.D. degree in 1983 from Purdue University under the direction of Dr. Ronald Somerville. After further postdoctoral research at Purdue University and with Dr. John Pringle at the University of Michigan, he joined the faculty in Microbiology and Molecular Genetics in 1988.
Research Interest
Dr. Johnson’s research group studied Cdc42-dependent cell signaling pathways in the yeasts Saccharomyces cerevisiae, Schizosaccharomyces pombe, and Candida albicans. Most recently, his group identified small molecules that inhibited biofilm formation and the morphological budded-to-hyphal transition in the pathogenic yeast C. albicans.
Publications
-
Grald, A., P. Yargosz, S. Case, K. Shea, and D.I. Johnson. Small molecule inhibitors of biofilm formation in laboratory and clinical isolates of Candida albicans.
-
Midkiff, J., N. Borochoff-Porte, D. White, and D.I. Johnson. Small molecule inhibitors of the Candida albicans budded-to-hyphal transition act through multiple signaling pathways
-
Toenjes, K.A., B.C. Stark, K.M. Brooks, D.K. Butler, and D.I. Johnson. Inhibitors of cellular signaling are cytotoxic or block the budded-to-hyphal transition in the pathogenic yeast Candida albicans.
